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The Department of Dermatology, New Yorh University School of Medicine, New Yorh, NY, U.S.A. 
Any introduction to a workshop on Langerhans cells must 
take into account the remarka ble historical background ofthese 
cells. In 1868, at the age of 21, Paul Langer hans, while studying 
the nervous system of the skin under the guidance of Rudolf 
Virchow and Julius Cohnheim, came upon these cells quite by 
accident. He described them as "dark bodies which are very 
distinct from epithelial cells" [1]. In spite of the fact that h e 
surely was working with a light microscope which would today 
be considered primitive, he was obviously able to identify their 
principal features. He described their suprabasal location and 
their dendrites, each having a button-like swelling at its end, 
and noted that some dendrites reached upward to the horny 
layer, while others extended downward through the lower layers 
of the epidermis. Only 2 features attributed by Langerhans to 
these cells have not been borne out; namely that they were part 
of the nervous system and that their dendrites reached into the 
dermis and connected with the nerve system there. 
The major developments leading to a better understanding 
of the nature and functions of Langerhans cells since Langer-
hans's time are listed in the Table. It is evident from this that 
there was a hiatus of almost a century before any significant 
progress in knowledge of the nature and functions of these cells 
was made. 
It is noteworthy that once again after all that time a seren-
dipitous observation led the way to the key discovery which 
precipitated the modern studies of the immunologic functions 
of Langerhans cells. Dr. lnga Silberberg was working in my 
department at New York University under an NIH grant for 
the study of the ultrastructural events occurring during pene-
tration of mercury into the skin. While investigating and com-
paring penetration of mercury in normal skin, in the skin of 
individuals who were contact-allergic to mercury and in irritant 
reactions to mercury, she frequently observed apposition of 
lymphocytes to Langerhans cells at sites of contact allergic 
reactions, while in normal skin and in irritant reactions there 
was usually no such apposition [2]. 
Her initial findings as well as subsequent investigations by 
her group [3] and by others clearly show that the epidermal 
Langerhans cell system is the body's first line of immunologic 
defense and is particularly suited to protect it against environ-
mental agents, since, under normal conditions, small molecules 
are the only ones which have the capacity to penetrate the skin. 
In contrast to conventional monocytic phagocytes which gen-
erally take up large molecules, Langerhans cells selectively take 
up small ones [ 4] and thus are eminently suited to serve this 
function in the epidermis. 
The Langerhans cell system has a remarkable functional 
capacity. Although Langerhans cells comprise only 4-5% of the 
epidermal cell compartment, their a bility to participate in im-
munologic reactions is tremendously enhanced by 3 features: 
1. Each cell has been shown t<i have up to 12 dendrites [5]. 
Therefore, if one assumes that each dendrite with its bulbous 
end portion has an immunologically reactive surface of about 
10% of the body of the Langerhans cell, then the total reactive 
smface of each cell is doubled by its dendrites. This would 
provide the equivalent immunological capacity of the epidermis 
containing 8-10% Langerhans cells minus their dendrites. 
2. Langerhans cells, contrary to previous concepts, now are 
known to be a migrating, rather than fixed, cell population, in 
the epidermis [3]. 
3. Under appropriate conditions many Langerhans cells can 
appear at a given site within a short period of time [3]. 
The capacity of these cells to participate in in1munologic 
reactions is therefore far greater than that of a nonmigrating 
cell population without dendrites and which make up 4 to 5% 
of the epidermis. 
The secretory functions of Langerhans cells h ave not yet 
been studied, but it appears likely t hat this subset of th e 
monocytic phagocyte series secretes and releases a variety of 
important chemical substances, much as other monocytic phag-
ocytes do. After more has been learned about these substances, 
it may be anticipated that the pathogenesis of some skin reac-
tions will be better understood. 
The finding that Langerhans cells are the antigen-presenting 
cells in contact-allergic reactions helps explain certain features 
of these reactions which until now have been difficult to under-
stand. Why, for example, are the early histologic epidermal 
changes in contact-allergic reactions seen in suprabasal loca-
tion? Since contact allergens in the environment enter the skin 
via the horny layer , one expected the first changes to occm in 
the outermost. living layers of the epidermis, just below ·th e 
horny layer. The fact is that the antigen-presenting Langerhans 
cells are predominantly located in the suprabasal layers, pro-
viding a reasonable explanation of a question long unanswered. 
Understanding the antigen-presenting functions of Langer-
hans cells further provides an alternative explanat ion for th e 
fact that, although the development of allergic contact sensiti-
zation is favored when first exposure to a contact allergen is via 
contact, fu·st exposure via the oral or parenteral route tends to 
favor the development of specific immunologic tolerance. Lan-
gerhans cells can serve their antigen-presenting functions to 
lymphocytes of the Ly 1 subclass when first exposm e is via 
contact. In contrast, when first exposw-e is via t he oral or 
parenteral route, the epidermal Langerhans cell system is by-
passed and the allergen exerts a direct tolerogenic effect on 
genetically susceptible lymphocytes, inducing specific immu-
nologic tolerance (6]. 
The immunologic role of Langerhans cells could also explain 
Major developments in the history of the Langerhans cell 
1868 discovered by Paul Langerhans-thought to be part of the 
nervous system 
1961 electron microscopic featmes described (Birbeck et al) 
1967 adenosine t riphosphatase (ATPase) demonstrated in Langer-
hans cell membrane (Wolff and Winkelmann) 
1973 apposition (peripolesis) of lymphocytes to Langerhans cells 
demonstrated and antigen presentation by La ngerhans cells 
suggested (S ilberberg) 
1974 migration of Langerha ns cells via dermal lymphatics to lymph 
nodes descnbed (Silberberg et a!) 
1976 " reticulo-epit helial trap" for contact allergens suggested (Shel-
ley and Juhlin) 
1977 cell mem.bra ne receptor for Fe fragment of lgG a nd comple-
ment (Stmgl et al) and Ia histocompatibility surface a ntigens 
(Klareskog et a l; Rowden et a l; Sting! et al) described 
1978 demonstration of ini t iation of immune response by Langerhans 
cells (Sting! et al) 
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certain differences which exist between contact-allergic and 
tuberculin-type reactions. It is quite conceivable, for instance, 
that while epidermal Langerhans cells are the presenting cells 
for the small molecular allergens which induce contact allergy, 
a predominantly epidermal form of reaction, conventional mon-
ocytic phagocytes could be the antigen-presenting cells in tu-
berculin-type reactions which are not caused by such small 
molecules, which take place in the dermis and do not involve 
the epidermis. 
Furthermore, it now appears that, contrary to previous con-
cepts, the contact allergen need not first conjugate with cuta-
neous proteins (keratin and collagen and their precursors) or 
serum proteins in the skin, before being taken up by the antigen-
presen ting Langerhans cells. Rather it seems increasingly likely 
t hat contact allergens combine with constituents of the Langer-
hans cell surface, perhaps gene products of the major histocom-
patibility complex, to form an immunogenic complex which 
then activates susceptible lymphocytes [7]. Thus direct com-
bination with th e Langerhans cell sur face could well be anoth er 
important difference from delayed tuberculin-type allergy, 
where small molecular allergens may have ·to combine with 
proteins in skin before being taken up by conventional macro-
phages. 
Yet another puzzling feature of contact allergy, at least in 
man, is the difficulty of passively transferring it with cells, and 
if indeed it can be transferred with cells, that such transfer 
occurs in a peculiar and irregular fashion. This is in sharp 
contrast to the easy transferability with cells of tuberculin-type 
delayed allergy in man. For successful passive transfer, the cell 
suspension , in addition to t he sensitized lymphocytes, must 
contain antigen-presenting cells bearing the same Ia antigens 
as t he antigen-presenting cells which induced the sensitivity in 
th e first place. Conventional mononuclear phagocytes, bearing 
the appropriate Ia antigens, which probably are the major 
antigen-presen ting cells for tuberculin-type hypersensitivity, 
are invariably present in peripheral blood and in buffy coat cell 
suspensions. In contrast there are no reports of Langerhans 
cells having been seen in buffy coat suspensions or blood 
obtained by venepuncture, although Langerhans cells have 
been seen in dermal capillaries [8]. Therefore the antigen-
presenting cells for contact allergy, bearing appropriate Ia an-
tigens, are likely to be either not present or present only in 
madequate numbers in buffy coat cell suspensions and trans-
fused blood. Thus the difference in transferability could be due 
to the different antigen-presenting cells which may be involved 
in these 2 forms of delayed allergy. 
In conclusion, it can be stated that recent research on Lan-
gerhans cells has already had a significant impact on our 
understanding of contact allergy. However, thus far no experi-
mental evidence has been published to indicate · that Langer-
hans cells are th e major antigen-presenting cells in delayed 
type reactions which mainly involve the dermis such as tuber-~ulin 1:eac~ions. Perhaps this is simply due to th'e early stage of 
mvestJgat10n of th1s problem, but it is possible that Langerhans 
cells may not play an importan t role in such dermal reactions. 
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DISCUSSION 
SHEV ACH: Langer hans cells pulsed with soluble protein an-
tigens do activate T cell proliferation in primed guinea pig T 
cells. Thus they may have a function in delayed (tuberculin-
type) hypersensitivity as well as in allergic contact dermatitis 
in vivo. 
BAER: It has been demonstrated that Langerhans cells take 
up large molecules like ferritin, but the question is, what is their 
major biologic function in clinical reactions in man? I suspect 
that they are cells, specifically designed to take up small mo-
lecular environmental substances, including allergens that 
reach the skin by contact from the outside and that they are 
not principally designed to deal with larger molecules, usually 
involved in tuberculin hypersensitivity. 
KATA: Would you please comment on Shelley and Juhlin's 
work which you quoted. It is my understanding that their 
findings were not restricted to potential allergens, that is, Lan-
gerhans cells picked up substances such as iron which is not to 
my knowledge an allergen. 
BAER: Yes, I think that is quite clear from their publications 
that they are not restricting their hypothesis regarding the 
preferential pick-up of simple chemicals by Langer hans cells to 
substances which are contact allergens. There is a question 
however, wheth er the events observed by Shelley and Juhlin in 
sections of nonliving skin also apply to Langerhans cells in 
living skin. 
GREEN: Langerhans cells and ordinary monocytes may have 
identical functions. Some of the differences between what hap-
pens in sensitization to contact allergens and sensitization to 
protein antigens is their mode of administration. Ordinary 
protein antigens are not rubbed on the skin. Reactive haptens 
are most often put on the skin directly (thus being a ble to react 
with Langerhans cells ). Reactive haptens are less often injected 
into the dermis. 
BAER: One of the questions, of course, which remains unre-
solved is wheth er Langerhans cells do indeed h ave a greater 
capacity to take up simple chemicals than do other mononu-
clear phagocytes. 
CLAMAN: The original experiment on contact sensitivity was 
done by injecting the allergens. 
LEVIS: Analogies of Langerhans cells and mononuclear phag-
ocytes are mainly through antigen presenting functions and 
surface receptor criteria as the langerhans cell is only poorly 
phagocytic. I would like to ask Z. Cohn if these cells have been 
studied for active pinocytosis and the dynamics of membrane 
internalization shown for macrophages. 
COHN: I really do not know if the membranes are very active. 
I am not aware of many studies that have been done on the 
endocytic activity of these cells. 
AUSTEN: Do Langerhans cells appear in mucosru surfaces? 
BAER: They have been found in mucosa! surfaces, in the 
mouth, the upper part of the respiratory tract, the upper part 
of the gastrointestinal tract and I think even in the lower parts 
of the gut. 
